ℹ️
🇬🇧
Search
Search for people relevant for "Phase A, B, C"
Phase A, B, C
Person
Class
Person
Publication
Programmes
PharmDr. Ján Stariat Ph.D.
Academic staff at Faculty of Pharmacy in Hradec Králové
15 publications
Publications
publication
Novel SPME fibers based on a plastic support for determination of plasma protein binding of thiosemicarbazone metal chelators: a case example of DpC, an anti-cancer drug that entered clinical trials
2019 |
Faculty of Pharmacy in Hradec Králové
publication
In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites
2015 |
Faculty of Pharmacy in Hradec Králové
publication
Simultaneous determination of the novel thiosemicarbazone anti-cancer agent, Bp4eT, and its main phase I metabolites in plasma: Application to a pilot pharmacokinetic study in rats
2014 |
Faculty of Pharmacy in Hradec Králové
publication
Identification of in vitro metabolites of the novel anti-tumor thiosemicarbazone, DpC, using ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry
2013 |
Faculty of Pharmacy in Hradec Králové
publication
Development of LC-MS/MS method for the simultaneous analysis of the cardioprotective drug dexrazoxane and its metabolite ADR-925 in isolated cardiomyocytes and cell culture medium
2013 |
Faculty of Pharmacy in Hradec Králové
publication
LC-MS/MS identification of the principal in vitro and in vivo phase I metabolites of the novel thiosemicarbazone anti-cancer drug, Bp4eT
2012 |
Faculty of Pharmacy in Hradec Králové
publication
Use of different stationary phases for separation of isoniazid, its metabolites and vitamin B6 forms
2011 |
Faculty of Pharmacy in Hradec Králové
publication
Hydrophilic interaction liquid chromatography in the separation of a moderately lipophilic drug from its highly polar metabolites - The cardioprotectant dexrazoxane as a model case
2011 |
Faculty of Pharmacy in Hradec Králové
publication
Pharmacokinetics of the cardioprotective drug dexrazoxane and its active metabolite ADR-925 with focus on cardiomyocytes and the heart
2018 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents
2015 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
Load more publications (5)
Loading network view...